Back
Assessing insulin effectiveness at the end of the day: Once-daily versus twice-daily insulin glargine injection
Mark R. Burge, Eric R. Schroeder, Stephen Mitchell
J. Diabetes Mellit. Vol.2 No.2, May 25, 2012  DOI: 10.4236/jdm.2012.22032
       (PDF  301K)     HTML      XML
Efficacy and Safety of Patient-Led Dosage Adjustments of Insulin Glargine: A Preliminary Report of Basal-Supported Oral Therapy for Japanese Type 2 Diabetes Patients
Shuhei Nakanishi, Mitsunobu Kubota, Rui Kishimoto
J. Diabetes Mellit. Vol.4 No.2, April 21, 2014  DOI: 10.4236/jdm.2014.42014
       (PDF  363K)     HTML     
Iowa medicaid 2: lapse of glycemic control on abrupt transition from insulin glargine to insulin detemir in type 2 diabetes mellitus
Udaya Kabadi
J. Diabetes Mellit. Vol.1 No.4, November 08, 2011  DOI: 10.4236/jdm.2011.14017
       (PDF  82K)     HTML     
From insulin detemir to glargine: Effect on glycemic control and psychological wellbeing in patients with diabetes mellitus type 2 in daily practice
Thiemo F. Veneman, Fred E. M. G. Storms, Ingo A. Eland, Paul K. P. Bouter
J. Diabetes Mellit. Vol.2 No.1, February 22, 2012  DOI: 10.4236/jdm.2012.21016
       (PDF  215K)     HTML     
Treatment Satisfaction with Insulin Glargine in Insulin-Naïve Type 2 Diabetes Patients—A Hong Kong Based Registry
Wing-Bun Chan, Wilson W. M. Ngai, Peter Chun-Yip Tong
J. Diabetes Mellit. Vol.4 No.3, August 21, 2014  DOI: 10.4236/jdm.2014.43033
       (PDF  2795K)     HTML     
 
 
Top